BioStock: First new US clinic initiated in RhoVac’s phase IIb study
Recruitment for RhoVac’s ongoing phase IIb study BRaVac is progressing in spite of the pandemic. The company’s CEO Anders Månsson tells BioStock that Urology Cancer Center in Omaha, Nebraska, was the first new study centre to be initiated in the US expansion initiative that was decided on last autumn. BioStock has contacted Månsson and the clinic’s founder Luke Nordquist to find out more.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se